Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients
about
Fitting and interpreting continuous-time latent Markov models for panel dataExpression of calcineurin activity after lung transplantation: a 2-year follow-upLongitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft DysfunctionRisk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation studyInteraction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.25-year follow-up after lung transplantation at Lund University Hospital in Sweden: superior results obtained for patients with cystic fibrosis.Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.Chronic lung allograft dysfunction after lung transplantation: the moving target.Pediatric lung transplantation: promise being realized.Current views on chronic rejection after lung transplantation.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Chronic lung allograft dysfunction phenotypes and treatment.Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients.Association of Higher CD4+ CD25high CD127low , FoxP3+ , and IL-2+ T Cell Frequencies Early After Lung Transplantation With Less Chronic Lung Allograft Dysfunction at Two Years.Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.Lung Transplantation
P2860
Q30641833-509135F4-ECD7-4E79-8844-3650DD212F7EQ34639769-F8902943-989C-467B-82DA-C9792AD7FA81Q35941658-7E8F094C-72B6-4706-A9C0-B19FEB240951Q36253928-2CD224B8-2302-49B5-AA36-4BA67D0155B0Q36541552-A25BB00C-B21D-4FC6-8257-92AEBCF30544Q36623201-4A015134-987D-4CAB-92E2-58251D1B943BQ36745407-37F42DEE-C19F-4F78-BD7D-C60C2968836DQ37069999-A42CEC04-AF6F-41EE-9996-A7ADEF3A899FQ37122569-8592D4F2-E0FD-4B98-A8D8-42FB72A3879AQ37179602-3F1410A1-3AFA-4061-8E4D-3983459A493EQ37247946-E541AA31-C6FF-40CF-BC8A-38D6EBBE8518Q37680499-ADE217AB-A299-4B40-96FB-EA3DD578DA7AQ37688479-D653E63B-F8D4-45D8-8CBF-590E0A4D4493Q37698328-4A811389-B2BA-4A5E-9A13-A37F76C83AA2Q38058746-D2871ECC-FEB0-48BC-AA4B-686175FFB66FQ38204614-E3461B07-D05E-45F9-A476-8FDAAA096C68Q38413323-B4098986-6162-4C61-8AEC-BB96E3B93EE0Q39366396-CCDC6605-4903-4EA3-B9BD-BCA216653DD4Q41303108-890C5223-1CA2-49D2-BFD5-AE7626C42DDFQ42768766-C9B86993-1C63-4B28-8BDE-72C72C22CE52Q44793703-60B81DBA-45D0-4BF9-BBD3-70C1DFA8CE8DQ48013021-57343017-9C35-4C6C-9FD1-5A1BE19149DEQ48024329-95B7977A-CEDD-4970-B6D5-29E9C74B3F39Q48277199-E1F063F9-EF68-4982-AAA0-FCC14586F2E5Q51751594-B0A545C4-1B34-4FAD-8F30-83525B05B8DAQ53346369-14AFC0F4-5895-4455-B91A-EF1BEFB65506Q55004572-0DC73401-99B5-4100-B3D8-619B15BAD2BCQ56505206-A60D9870-91C5-4819-A624-DE3D4929F61D
P2860
Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Survival after bronchiolitis o ...... ral lung transplant recipients
@ast
Survival after bronchiolitis o ...... ral lung transplant recipients
@en
Survival after bronchiolitis o ...... ral lung transplant recipients
@nl
type
label
Survival after bronchiolitis o ...... ral lung transplant recipients
@ast
Survival after bronchiolitis o ...... ral lung transplant recipients
@en
Survival after bronchiolitis o ...... ral lung transplant recipients
@nl
prefLabel
Survival after bronchiolitis o ...... ral lung transplant recipients
@ast
Survival after bronchiolitis o ...... ral lung transplant recipients
@en
Survival after bronchiolitis o ...... ral lung transplant recipients
@nl
P2093
P2860
P1476
Survival after bronchiolitis o ...... ral lung transplant recipients
@en
P2093
C Ashley Finlen Copeland
David W Zaas
Scott M Palmer
W Austin Davis
W Jackson Turbyfill
P2860
P304
P356
10.1164/RCCM.201002-0211OC
P407
P577
2010-05-27T00:00:00Z